Group 1 - The core revenue of the company for the six months ending June 30, 2025, remained stable at HKD 1.498 billion, representing a year-on-year decrease of 1% [1] - The company's loss attributable to shareholders was HKD 108 million, an improvement of HKD 35 million compared to a loss of HKD 143 million in the same period last year [1] - The loss per share was HKD 0.23, compared to HKD 0.33 in 2024 [1] Group 2 - The total revenue from the core television-related business (excluding e-commerce) increased by HKD 9 million or 1% to HKD 1.454 billion, driven by a 4% growth in advertising revenue and a 9% increase in digital media revenue [1] - The board of directors does not recommend the distribution of an interim dividend for this period, consistent with the previous year [1]

Group 1 - The core point of the article is that Guo En Holdings (stock code: 8121) announced a new share placement to raise approximately HKD 30 million, with net proceeds expected to be around HKD 27 million after expenses [1] - The placement involves issuing up to 5,000,000 new shares at a price of HKD 0.60 per share, which represents an 11.8% discount compared to the previous closing price of HKD 0.68 [1] - The new shares will account for approximately 20.0% of the existing issued share capital and about 16.7% of the enlarged share capital after the placement [1] Group 2 - The funds raised will primarily support the development of the company's healthcare business, including hiring talent, covering daily expenses, conducting marketing activities, and developing sales platforms [1] - The placement is conducted under a general mandate granted by the shareholders' meeting and is expected to be completed within five business days after the fulfillment of the placement agreement's conditions [1]